HSF - Hidradenitis Suppurativa (HS) Clinical Trials, Research Studies & Meetings

“Furthermore, as pain is an important feature of HS a subjective evaluation should be included, preferably a visual analogue scale score
of pain from the worst lesion as chosen by the patient.”
K. Sartorius et al. 2003

Clinical Trials for Hidradenitis Suppurativa (HS) and Medical Meeting presentations on HS in recent years demonstrates a continuing concern of doctors worldwide to discuss and research this disease in many and varied medical and scientific forums, symposia and meetings. As of 8/14/09, the Medical Meetings section on this page has been discontinued.

In addition, there is a growing body of research indicating the use of biologic medications in the management of HS. "The evidence base and rationale for the use of anti-TNFa biologic drugs for the treatment of Hidradenitis Suppurativa: an advocacy report from the Hidradenitis Suppurativa Foundation, Inc." by Robert Howes and Michelle Barlow (9 May 2007) can be downloaded HERE.

CLINICAL TRIALS & BASIC RESEARCH PROJECTS

Randomized Control Trial Comparing Efficacy of Antibiotic Therapy Alone Versus Antibiotic Therapy in Conjunction With Quadruple Pulse Therapy Using NdYag Laser in Treatment of Hidradenitis Suppurativa Link

A Phase 2 MULTICENTER Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa. Link

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Compared With Placebo In The Treatment Of Hidradenitis Suppurativa. Link

The Role of Cytokines in Inflammatory Skin Conditions that Result in Scarring. Link

Molecular Etiology of Hidradenitis Suppurativa (0313660- a German Federal Ministry of Education and Research-supported project).Link

Investigation to determine treatment effects of Long-Pulsed Nd:YAG Laser Hair Removal on Hidradenitis Suppurativa. Link

Open Label Clinical Trial Etanercept for Treatment of Hidradenitis. Link

Research Study- Treatment of Hidradenitis Suppurativa with Etanercept injection. Link

completed CLINICAL TRIALS

A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa.
Interventional Study October 2006 to Unknown completion date. Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study. University of Kansas Medical Center, Kansas City, Kansas, 66160, United States. Link

Open-Label Assessment of the Efficacy & Safety of Efalizumab in the Treatment of Mod-Severe Hidradenitis Suppurativa.
PHASE 1, February 2005 to February 2006, New York University School of Medicine, Dept. of Dermatology, New York, New York, 10016, United States; STUDY COMPLETED. Link

Non Randomized, Open Label, Uncontrolled Study of the Safety and Efficacy of Etanercept for the Therapy of Hidradenitis Suppurativa.
PHASE II, Sept. 2005 to May 2007. Department of Internal Medicine, University of Athens, Medical School, Athens, 124 64 Greece; STUDY COMPLETED. Link

To Determine The Efficacy Of A 1320nm Nd: YAG Nonablative Laser For Treatment of Hidradenitis Suppurativa.
PHASE II. April 2005-April 2007. Univ. of California, Davis Medical Center Dept. of Dermatology, Sacramento, California, 95817, United States; STUDY COMPLETED. Link